• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A fresh look into the pathophysiology of ischemia-induced complications in patients with chronic kidney disease undergoing hemodialysis.对接受血液透析的慢性肾病患者缺血性并发症病理生理学的新审视。
Int J Nephrol Renovasc Dis. 2015 Mar 13;8:25-8. doi: 10.2147/IJNRD.S75960. eCollection 2015.
2
The impact of chronic kidney disease on lower extremity bypass outcomes in patients with critical limb ischemia.慢性肾脏病对伴有严重肢体缺血的下肢旁路手术结局的影响。
J Vasc Surg. 2019 Feb;69(2):491-496. doi: 10.1016/j.jvs.2018.05.229. Epub 2018 Aug 25.
3
Impact of chronic kidney disease and stress myocardial perfusion imaging as a predictor of cardiovascular events.慢性肾脏病和应激心肌灌注成像对心血管事件的预测作用。
Ann Nucl Med. 2011 Nov;25(9):616-24. doi: 10.1007/s12149-011-0507-x. Epub 2011 Jul 1.
4
[Molecular mechanisms for uremic toxin-induced oxidative tissue damage via a cardiovascular-renal connection].[通过心血管-肾脏联系的尿毒症毒素诱导氧化组织损伤的分子机制]
Yakugaku Zasshi. 2013;133(8):889-95. doi: 10.1248/yakushi.13-00170.
5
Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study.Elbasvir/grazoprevir 治疗合并慢性肾脏病(包括透析患者)的 1b 型慢性丙型肝炎日本患者的疗效和安全性:一项多中心研究的事后分析。
J Gastroenterol Hepatol. 2019 Feb;34(2):364-369. doi: 10.1111/jgh.14447. Epub 2018 Sep 14.
6
Experimental chronic kidney disease attenuates ischemia-reperfusion injury in an ex vivo rat lung model.实验性慢性肾病减轻离体大鼠肺模型中的缺血再灌注损伤。
PLoS One. 2017 Mar 14;12(3):e0171736. doi: 10.1371/journal.pone.0171736. eCollection 2017.
7
Cardiovascular risk in hemodialysis patients: a mechanistic approach.
Int J Artif Organs. 2007 Nov;30(11):1020-7. doi: 10.1177/039139880703001112.
8
Nuclear Respiratory Factor-1 (NRF-1) Gene Expression in Chronic Kidney Disease Patients Undergoing Hemodialysis and Mitochondrial Oxidative Dysregulation.接受血液透析的慢性肾脏病患者的核呼吸因子-1(NRF-1)基因表达与线粒体氧化调节异常
Clin Lab. 2016 Nov 1;62(11):2149-2154. doi: 10.7754/Clin.Lab.2016.160329.
9
Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention.对比剂诱导的急性肾损伤与行急诊经皮冠状动脉介入治疗的慢性肾脏病急性冠状动脉综合征患者长期心血管事件的相关性。
Int J Cardiol. 2014 Jun 1;174(1):57-63. doi: 10.1016/j.ijcard.2014.03.146. Epub 2014 Mar 28.
10
Reduced Cardiovascular Mortality Associated with Early Vascular Access Placement in Elderly Patients with Chronic Kidney Disease.老年慢性肾脏病患者早期血管通路置入与心血管死亡率降低相关。
Am J Nephrol. 2016;43(5):334-40. doi: 10.1159/000446159. Epub 2016 May 11.

引用本文的文献

1
Editorial over the Many Faces of Vitamin D in Chronic Kidney Disease: from Mineral to Immune-Inflammatory Modulator.慢性肾脏病中维生素D的多面性社论:从矿物质调节剂到免疫炎症调节剂
Inflammation. 2018 Mar;41(2):365-367. doi: 10.1007/s10753-017-0707-1.

本文引用的文献

1
Levels of arginine and its products in dialysis patients.透析患者体内精氨酸及其产物的水平。
Eur Rev Med Pharmacol Sci. 2014 Aug;18(16):2357-64.
2
Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease.心血管疾病与慢性肾脏病患者肠道摄取对甲酚有关。
BMC Nephrol. 2014 Jun 9;15:87. doi: 10.1186/1471-2369-15-87.
3
Gut bacterial translocation may aggravate microinflammation in hemodialysis patients.肠道细菌易位可能会加重血液透析患者的微炎症。
Dig Dis Sci. 2014 Sep;59(9):2109-17. doi: 10.1007/s10620-014-3202-7. Epub 2014 May 15.
4
Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis.随机临床试验:鼠李糖乳杆菌 GG 可调节肝硬化患者的肠道微生物组、代谢组和内毒素血症。
Aliment Pharmacol Ther. 2014 May;39(10):1113-25. doi: 10.1111/apt.12695. Epub 2014 Mar 16.
5
P-cresyl sulfate is a valuable predictor of clinical outcomes in pre-ESRD patients.对 pre-ESRD 患者而言,硫酸对甲酚是临床结局的一个有价值的预测指标。
Biomed Res Int. 2014;2014:526932. doi: 10.1155/2014/526932. Epub 2014 Jan 29.
6
Numerous protein-bound solutes are cleared by the kidney with high efficiency.许多与蛋白结合的溶质被肾脏高效清除。
Kidney Int. 2013 Sep;84(3):585-90. doi: 10.1038/ki.2013.154. Epub 2013 May 1.
7
Newly designed CRRT membranes for sepsis and SIRS--a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review.新型 CRRT 膜在脓毒症和 SIRS 中的应用——床边重症监护医师实用方法综述:系统的结构化综述。
ASAIO J. 2013 Mar-Apr;59(2):99-106. doi: 10.1097/MAT.0b013e3182816a75.
8
The vagal innervation of the gut and immune homeostasis.肠道的迷走神经支配与免疫稳态。
Gut. 2013 Aug;62(8):1214-22. doi: 10.1136/gutjnl-2012-302550. Epub 2012 Sep 29.
9
Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients--a prospective cohort study.血清游离对甲酚硫酸盐水平可预测老年血液透析患者的心血管和全因死亡率——一项前瞻性队列研究。
Nephrol Dial Transplant. 2012 Mar;27(3):1169-75. doi: 10.1093/ndt/gfr453. Epub 2011 Sep 2.
10
p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.对甲酚硫酸盐和吲哚硫酸盐可预测慢性肾脏病的进展。
Nephrol Dial Transplant. 2011 Mar;26(3):938-47. doi: 10.1093/ndt/gfq580. Epub 2010 Sep 29.

对接受血液透析的慢性肾病患者缺血性并发症病理生理学的新审视。

A fresh look into the pathophysiology of ischemia-induced complications in patients with chronic kidney disease undergoing hemodialysis.

作者信息

Honore Patrick M, Jacobs Rita, De Waele Elisabeth, Van Gorp Viola, De Regt Jouke, Joannes-Boyau Olivier, Boer Willem, Spapen Herbert D

机构信息

Intensive Care Department, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.

Intensive Care Unit, Haut Leveque University Hospital of Bordeaux, University of Bordeaux 2, Pessac, France.

出版信息

Int J Nephrol Renovasc Dis. 2015 Mar 13;8:25-8. doi: 10.2147/IJNRD.S75960. eCollection 2015.

DOI:10.2147/IJNRD.S75960
PMID:25792850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4364590/
Abstract

Recent case reports of acute esophageal necrosis in patients with chronic kidney disease (CKD) undergoing hemodialysis encouraged us to look beyond hypoperfusion/ischemia as a sole explanation for this dramatic complication. At least three intriguing pathways, ie, accumulation of protein-bound toxins, endotoxin translocation, and altered mucosal defense mechanisms, have been proposed to explain the inherent susceptibility of CKD patients to developing ischemia-related and cardiovascular events. Interestingly, all the proposed pathways can be potentially antagonized or attenuated. At present, however, it is not known whether one pathway predominates or if any interaction exists between these pathways. More solid experimental and clinical data are warranted to acquire a better insight into the complex pathogenesis of CKD-associated ischemia.

摘要

近期有关于接受血液透析的慢性肾脏病(CKD)患者发生急性食管坏死的病例报告,这促使我们不再将低灌注/缺血作为这一严重并发症的唯一解释。至少有三种引人关注的途径,即蛋白结合毒素的蓄积、内毒素移位和黏膜防御机制改变,被提出用以解释CKD患者发生缺血相关事件和心血管事件的内在易感性。有趣的是,所有提出的途径都可能被潜在地拮抗或减弱。然而,目前尚不清楚是一种途径占主导,还是这些途径之间存在相互作用。需要更确凿的实验和临床数据,以便更好地洞察CKD相关缺血的复杂发病机制。